PharmGen Science팜젠사이언스
004720 · KOSPI · ₩004720 · 팜젠사이언스
₩2,750▲ ₩10 (0.36%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Corporate value-up plan기업가치제고계획(자율공시) (PBR 개선 계획 제출 기업)Oct 22, 2026Open on DART
Predicted impact: Low
Routine value-up plan filed for a PBR improvement; no specific financial action stated.
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 14, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)May 15, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 12, 2026Open on DART
- Exercise of Conversion Right, Preemptive Right for New Shares, and Exchange Right전환청구권ㆍ신주인수권ㆍ교환청구권행사May 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 12, 2026Open on DART
- Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 23, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 23, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)Mar 11, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 9, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 18, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 18, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 18, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 18, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 18, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 18, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서(최대주주변경시)Dec 12, 2025Open on DART
- Change of largest shareholder최대주주변경Dec 12, 2025Open on DART
- Exercise of Conversion Right, Preemptive Right for New Shares, and Exchange Right전환청구권ㆍ신주인수권ㆍ교환청구권행사Dec 12, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Amended: Half-year report (Jun 2025)[기재정정]반기보고서 (2025.06)Aug 19, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Exercise of Conversion Right, Preemptive Right for New Shares, and Exchange Right전환청구권ㆍ신주인수권ㆍ교환청구권행사Aug 12, 2025Open on DART
- Exercise of Conversion Right, Preemptive Right for New Shares, and Exchange Right전환청구권ㆍ신주인수권ㆍ교환청구권행사Jun 12, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 14, 2025Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)Apr 11, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Apr 10, 2025Open on DART
- Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Apr 3, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 3, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2025Open on DART
- Audit report submitted감사보고서제출Mar 21, 2025Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 21, 2025Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 21, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: PharmGen Science / 팜젠사이언스 / 004720 / KRX:004720
Source: KRX statistical information